Condition: Recurrent Respiratory Tract Infections · Sponsor: Min-Tze LIONG
This study is an 8-weeks, randomized controlled trial involving children under 6 years of age who meet clinical diagnostic criteria for RRTI. Participants are randomized to receive either probiotic or placebo. The primary clinical outcomes assessed are duration and frequency of respiratory symptoms and quality of life. To investigate potential mechanisms, stool samples were collected pre- and post-intervention for metagenomics gene sequencing to analyze changes in gut microbiota composition and identify specific bacterial taxa associated with clinical improvements.
This description comes directly from the study's public registry record.
Min-Tze Liong, Ph.D. · 6046532114 · mintze.liong@usm.my
Jie Yuan, M.Sc. · 822137027899 · peanut.yuan@diprobio.com
Always discuss trial participation with your own doctor first.
| Xinyi City People's Hospital | Xingyi, Guangdong, China | Recruiting |
| Universiti Sains Malaysia | George Town, Pulau Pinang, Malaysia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07297966